Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.

Show More



Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue's InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. With the ability to run a same-slide fluorescent and H&E stain, Ultivue's technology is enabling pathologists to connect traditional morphological analysis with multiplexed immunofluorescent data for comprehensive single-cell phenotyping.

Show More
  • MAY 26, 2021 9:00 AM PDT
    MAY 26, 2021 9:00 AM PDT
    Date: May 26, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors but is challenged in that only a minority of patie...
  • APR 16, 2020 9:00 AM PDT
    APR 16, 2020 9:00 AM PDT
    DATE: April 16, 2020 TIME: 9:00am PT, 12:00pm ET There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing...
  • MAR 21, 2019 7:00 AM PDT
    MAR 21, 2019 7:00 AM PDT
    DATE:  March 21,  2019TIME:  7:00am PDT, 10:00am EDT The benefits of multiplex immunohistochemistry assays for tissue analysis are numerous. High-level multipl...